These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20798543)

  • 1. Liquid drugs and high dead space syringes may keep HIV and HCV prevalence high - a comparison of Hungary and Lithuania.
    Gyarmathy VA; Neaigus A; Li N; Ujhelyi E; Caplinskiene I; Caplinskas S; Latkin CA
    Eur Addict Res; 2010; 16(4):220-8. PubMed ID: 20798543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary.
    Gyarmathy VA; Neaigus A; Mitchell MM; Ujhelyi E
    Drug Alcohol Depend; 2009 Mar; 100(3):240-7. PubMed ID: 19058925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug users who self-reported being infected with hepatitis C virus or human immunodeficiency virus.
    Gyarmathy VA; Neaigus A; Li N; Ujhelyi E; Caplinskiene I; Caplinskas S; Latkin CA
    Scand J Infect Dis; 2011 Jan; 43(1):32-42. PubMed ID: 20840002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
    Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
    Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary-An expanding public health burden.
    Tarján A; Dudás M; Wiessing L; Horváth G; Rusvai E; Tresó B; Csohán Á
    Int J Drug Policy; 2017 Mar; 41():1-7. PubMed ID: 27984762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.
    Miller M; Mella I; Moi H; Eskild A
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):373-9. PubMed ID: 12843749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest.
    Rácz J; Gyarmathy VA; Neaigus A; Ujhelyi E
    AIDS Care; 2007 Jan; 19(1):59-66. PubMed ID: 17129858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug injecting and HIV risk among injecting drug users in Hai Phong, Vietnam: a qualitative analysis.
    Ahmed T; Long TN; Huong PT; Stewart DE
    BMC Public Health; 2015 Jan; 15():32. PubMed ID: 25631330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dead-space syringes and the risk of HIV and HCV infection among injecting drug users.
    Zule WA; Bobashev G
    Drug Alcohol Depend; 2009 Mar; 100(3):204-13. PubMed ID: 19004579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of hepatitis C and human immunodeficiency virus infections among injecting drug users in Hungary--what's next?].
    Gyarmathy VA; Rácz J
    Orv Hetil; 2010 Mar; 151(10):365-71. PubMed ID: 20178967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
    Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of high-risk drug use and coverage of opioid substitution treatment and needle and syringe programs in Lithuania in 2015-2016: A multi-method estimation study.
    Thanki D; Mravčík V; Běláčková V; Mačiulytė D; Zábranský T; Širvinskienė A; Subata E; Lorenzo-Ortega R
    J Subst Abuse Treat; 2021 Mar; 122():108229. PubMed ID: 33509418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro.
    Judd A; Rhodes T; Johnston LG; Platt L; Andjelkovic V; Simić D; Mugosa B; Simić M; Zerjav S; Parry RP; Parry JV
    BMC Infect Dis; 2009 Feb; 9():14. PubMed ID: 19203380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsafe injecting practices among attendees of syringe exchange programmes in France.
    Valenciano M; Emmanuelli J; Lert F
    Addiction; 2001 Apr; 96(4):597-606. PubMed ID: 11300963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan.
    Yen YF; Yen MY; Su LW; Li LH; Chuang P; Jiang XR; Deng CY
    BMC Public Health; 2012 Dec; 12():1066. PubMed ID: 23227904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for hepatitis C virus infection among injecting drug users in Sydney.
    van Beek I; Buckley R; Stewart M; MacDonald M; Kaldor J
    Genitourin Med; 1994 Oct; 70(5):321-4. PubMed ID: 8001943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.